METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical …

K Ao, M Yin, X Lyu, Y Xiao, X Chen, S Zhong, X Wen… - Cancer Letters, 2024 - Elsevier
The role of RNA methyltransferase 3 (METTL3) in tumor progression when tethered to
aberrantly expressed oncogenes remains unknown. In especial, the correlation between …

METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical …

K Ao, M Yin, X Lyu, Y Xiao, X Chen, S Zhong… - Cancer Letters, 2024 - europepmc.org
The role of RNA methyltransferase 3 (METTL3) in tumor progression when tethered to
aberrantly expressed oncogenes remains unknown. In especial, the correlation between …

METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical …

K Ao, M Yin, X Lyu, Y Xiao, X Chen, S Zhong… - Cancer … - pubmed.ncbi.nlm.nih.gov
The role of RNA methyltransferase 3 (METTL3) in tumor progression when tethered to
aberrantly expressed oncogenes remains unknown. In especial, the correlation between …